Vault-13

TRV GP II, LLC

Boston, MA · CIK 1614073 · 13F filing filed 2022-08-12

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$4.6m reported value -52.9% vs Q1 2022
2positions
100.0%in top 10
0 new 0 added 0 reduced 0 sold out vs Q1 2022

This report includes the holdings of 2 other managers that share the investment decisions:

Also in the report of:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 JOUNCE THERAPEUTICS INC COM JNCE JNCE 1,347,829 $4.1m88.46% 88.46% UnchangedShares held: Q3 2021 2.7m, Q4 2021 2.7m, Q1 2022 1.3m, Q2 2022 1.3m
2 ALLENA PHARMACEUTICALS COM ALNA ALNA 2,790,964 $533.0k11.54% 11.54% UnchangedShares held: Q3 2021 2.8m, Q4 2021 2.8m, Q1 2022 2.8m, Q2 2022 2.8m